P A G E 3
We continued to face a challenging health care environment in fiscal year 2022, exacerbated by the
uncertainty of future abortion access. Despite these challenges, we prioritized access to care and
improved our service delivery to ensure all patients have an excellent experience at PPSP.
PPSP continues to serve the four counties as both
a safety-net provider and a provider of choice.
We provide low-cost to no-cost care along an
income-based sliding-fee scale for uninsured and
underinsured patients. 30% of visits provided
were to self-pay patients, and 77% of these
patients received free or reduced-fee care. 37%
of our patients were covered by Medicaid and
the remaining 33% used commercial health
insurance.
8,118 abortions were performed, 67% of which
were medication abortions. Of these, 254 were
provided through telemedicine. After a pause in
our Residents’ Training Program due to
pandemic safety protocols, we resumed training
Ob/Gyn residents at 1144 Locust. Along with our
national office and other abortion providers in
Pennsylvania, we prepared for a post-Roe
environment and its impact on services.
In our fifth year providing Gender Affirming Care,
we provided 281 care-initiation visits and 1,236
follow-up appointments through telemedicine
and at Pottstown, West Chester, and Center City,
Philadelphia.
With increased numbers of patients expressing
the desire for in-person care, we saw the demand
for telemedicine appointments decrease. As we
are deeply committed to removing barriers and
making health care accessible to all, we will
continue to offer both traditional and
telemedicine visits.
Our Clinical Research team participated in 6
studies, enrolling over 130 participants and
helping to connect our patients to innovative
treatments and care. We also received a grant to
expand our capacity and infrastructure to conduct
abortion research studies, a critically important
project as we prepare to participate in examining
the effects of abortion restrictions post-Roe.
Patient
Services
We provided 43,607 sexual and reproductive health visits for 33,709 people. Our patients rated
our care highly, with 91% indicating that they recommend our services to others.